N. Sirvent

Genetic polymorphisms and childhood acute lymphoblastic leukemia: GWAS of the ESCALE study (SFCE)

R. Scott, D. Hémon, A. Baruchel, 2012, Leukemia.

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

Y. Bertrand, A. Uyttebroeck, B. De Moerloose, 2010, Blood.

Improved outcome with pulses of vincristine and corticosteroids in continuation therapy of children with average risk acute lymphoblastic leukemia (ALL) and lymphoblastic non-Hodgkin lymphoma (NHL): report of the EORTC randomized phase 3 trial 58951.

Y. Bertrand, A. Uyttebroeck, B. De Moerloose, 2010, Blood.

Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA)

P. Auquier, N. Sirvent, R. Reynaud, 2012, Bone Marrow Transplantation.

Growth deceleration in children treated with imatinib for chronic myeloid leukaemia.

A. Baruchel, T. Leblanc, Y. Bertrand, 2014, European journal of cancer.